These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 33023754)
1. Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history. Alobuia WM; Ammar S; Tyagi M; Ghosh C; Gunda V; Annes JP; Kebebew E Surgery; 2021 Feb; 169(2):298-301. PubMed ID: 33023754 [TBL] [Abstract][Full Text] [Related]
2. Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Nockel P; El Lakis M; Gaitanidis A; Yang L; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E Surgery; 2018 Jan; 163(1):191-196. PubMed ID: 29126554 [TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population. Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040 [TBL] [Abstract][Full Text] [Related]
4. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up. Stenman A; Zedenius J; Juhlin CC Surgery; 2019 Nov; 166(5):901-906. PubMed ID: 31239074 [TBL] [Abstract][Full Text] [Related]
5. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy. Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159 [TBL] [Abstract][Full Text] [Related]
6. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center. Asban A; Kluijfhout WP; Drake FT; Beninato T; Wang E; Chomsky-Higgins K; Shen WT; Gosnell JE; Suh I; Duh QY J Surg Oncol; 2018 May; 117(6):1217-1222. PubMed ID: 29315604 [TBL] [Abstract][Full Text] [Related]
7. When Biochemical Phenotype Predicts Genotype: Pheochromocytoma and Paraganglioma. Yan Q; Bancos I; Gruber LM; Bancos C; McKenzie TJ; Babovic-Vuksanovic D; Young WF Am J Med; 2018 May; 131(5):506-509. PubMed ID: 29391129 [No Abstract] [Full Text] [Related]
8. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730 [TBL] [Abstract][Full Text] [Related]
9. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea. Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185 [TBL] [Abstract][Full Text] [Related]
10. SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma. Assadipour Y; Sadowski SM; Alimchandani M; Quezado M; Steinberg SM; Nilubol N; Patel D; Prodanov T; Pacak K; Kebebew E Surgery; 2017 Jan; 161(1):230-239. PubMed ID: 27839933 [TBL] [Abstract][Full Text] [Related]
11. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma. Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557 [TBL] [Abstract][Full Text] [Related]
16. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma. Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434 [TBL] [Abstract][Full Text] [Related]
18. Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma. Rana HQ; Rainville IR; Vaidya A Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):166-76. PubMed ID: 24739310 [TBL] [Abstract][Full Text] [Related]
19. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma. Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621 [TBL] [Abstract][Full Text] [Related]
20. Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield. Horton C; LaDuca H; Deckman A; Durda K; Jackson M; Richardson ME; Tian Y; Yussuf A; Jasperson K; Else T J Clin Endocrinol Metab; 2022 Apr; 107(5):e1917-e1923. PubMed ID: 35026032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]